Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT for CP: Autologous Cell Therapies for Cerebral Palsy
NCT01988584Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Nov 2013
- Primary completion
- Feb 2018
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood, bone marrow mononuclear cells in cerebral palsy (CP), sponsored by UTHealth Houston. Started Nov 2013; status: completed.
02
Drugs
umbilical cord bloodbone marrow mononuclear cells
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT01988584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01988584.